AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MUMBAI, April 1 Asia Pulse - Pharmaceutical company Suven Life Sciences (BSE:530239) on Monday said it has received product patents in Mexico and Korea for two of their new chemical entities for the treatment of disorders associated with neuro-degenerative diseases.
"We are very pleased by the issuance of these patents to Suven for our drug candidates that are being developed for Central Nervous System disorders which targets an US$18 billion potential market opportunity globally," Suven Life CEO Venkat Jasti said.
These granted patents are exclusive intellectual property of Suven and were achieved through exclusive internal discovery research efforts, the company said in a filing to the Bombay Stock Exchange.
Products out of these inventories, which are in pre-clinical development, ...
Source: HighBeam Research, INDIA'S SUVEN GETS PRODUCT PATENTS IN KOREA, MEXICO.